Shira Modai
About Shira Modai
Shira Modai serves as the Vice President of Clinical Genomics at Variantyx, where she has worked since 2021. She has an extensive background in genomics and microbiology, holding advanced degrees from Tel Aviv University and experience in various roles within the company since 2014.
Work at Variantyx
Shira Modai currently serves as the Vice President of Clinical Genomics at Variantyx, a position she has held since 2021. In this role, she oversees clinical genomics initiatives, contributing to the development and implementation of genomic solutions. Prior to this, she held multiple positions at Variantyx, including Managing Director from 2019 to 2021, Clinical Coordinator from 2014 to 2016, and Director of Clinical Operations from 2016 to 2019. Her extensive experience at Variantyx spans over seven years, highlighting her deep involvement in the company's clinical operations and genomic projects.
Education and Expertise
Shira Modai's educational background includes a Doctor of Philosophy (Ph.D.) in miRNA and Virology from the Sackler School of Medicine at Tel Aviv University, which she completed between 2008 and 2014. She also holds a Master's Degree in Microbiology and Physiology from the same institution, achieved from 2005 to 2007. Earlier, she earned a Bachelor of Science (B.Sc.) in Biotechnology and Food Engineering from the Technion - Israel Institute of Technology, studying from 2000 to 2004. This diverse educational foundation supports her expertise in clinical genomics and related fields.
Background
Shira Modai began her career in the Functional Genomics Lab at Tel Aviv University, where she worked as a Technician from 2013 to 2015. This role provided her with foundational experience in genomics and laboratory techniques. Her career trajectory has been marked by progressive responsibilities in clinical genomics, particularly at Variantyx, where she has played a significant role in various capacities since 2014.
Professional Experience
Shira Modai has accumulated significant professional experience in the field of clinical genomics. She worked as a Clinical Coordinator at Variantyx from 2014 to 2016, followed by a role as Director of Clinical Operations from 2016 to 2019. Her tenure as Managing Director from 2019 to 2021 further solidified her leadership capabilities within the organization. Each of these roles contributed to her current position as Vice President of Clinical Genomics.